← SynDRA
RIMONABANT
SynDRA canonical compound SYN0000827 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Primary target(s) | CNR1 |
|---|
| Mechanism of action | Cannabinoid receptor antagonist |
|---|
All known targets
- CNR1
- GPR55
- ACHE
- CNR2
- Cnr1
- Cnr2
- GPR18
- IL6
- KCNH2
Mechanisms of action (all sources)
- Cannabinoid receptor antagonist
- CNR1 ANTAGONIST
- Cannabinoid CB1 receptor antagonist
- GPR55 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HCRTR1
- ADORA3
- OPRK1
- OPRM1
- CHRM2
- PDE3A
- NR1I3
- ESR2
- CYP2C9
- ABCC1
- HTR2A
- ABCB11
- ABCC4
- HTR3A
- NEIL1
- NR1I2
- NR1H4
- NR1H3
- NR1H2
- HTR2B
- NPY2R
- NPY1R
- NEIL2
- MPG
- HTR5A
- MLNR
- MGAT2
- MC4R
- HTR2C
- MBD4
- MAOA
- KDR
- KAT2A
- HTR7
- HTR6
- MC3R
- OGG1
- NR3C1
- NTHL1
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ALOX12
- ANDR
- CP2C9
- CP3A7
- ESRRA
- GEMI
- KSYK
- LOX12
- PRGR
- RXFP1
- SYK
Drug classes
- Anti-Obesity Agents
- Cannabinoid Receptor Antagonists
- Cannabinoid Receptor Modulators
- Hormones
- Neurotransmitter Agents
ATC classes
- A08A · ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
Cross-references
Synonyms
- SR141716A
- acomplia
- SR141716
- Zimulti
- SR-14171
- SR-141716
- SR-141716A
- Acomplia
- Riobant
- Slimona
- [3H]SR141716A
- Acomplia (TN)
- Bethin (TN)
- Monaslim (TN)
- Remonabent (TN)
- Rimonabant [USAN:INN]
- Rimoslim (TN)
- Riobant (TN)
- Riomont (TN)
- Slimona (TN)
- Zimulti (TN)
- Rimonabant (JAN/USAN/INN)
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide
- 5-(p-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide
- SR 141716A
- A 281
- RML78EN3XE
- DTXCID1026453
- CHEBI:34967
- rimonabantum
- RefChem:389265
- A08AX01
- Rimonabant free base
- MFCD04034714
- Rimonabant (SR141716)
- Rimoslim
- C22H21Cl3N4O
- s3021
Look up RIMONABANT in the interactive SynDRA portal →